Nom:Acétate de ganirelix
Taper:Peptides GMP
Séquence:Ac-D-2-Nal-D-4-ClPhe-D-3-Pal-Ser-Tyr-D-Lys(C(NHEt)
N ° CAS:123246-29-7
Impureté unique(CLHP):1.0%
Teneur en peptides(N %):80%(par %N)
Teneur en acide(CLHP):15.0%
Équilibre de la masse:95.0~105,0 %
MW :1570.4
Formule :C80H113N18O13Cl
Pureté(CLHP):98.0%
Apparence:poudre blanche
Composition en acides aminés:10% de théétique
Teneur en eau(Karl Fischer):6.0%
Ganirelix is a synthetic decapeptide compound. Its acetate, Ganirelix Acetate, releasing hormone (GnRH) receptor antagonist. The amino acid sequence is: Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-Tyr-D-HoChemicalbookmoArg(9,10-Et2)-Leu-L-HomoArg(9,10-Et2)-Pro-D- Ala-NH2. Clinically, it is mainly used in women receiving assisted reproductive technology in controlled ovarian stimulation programs to prevent premature lutei nizing hormone peaks and to treat fertility disorders caused by this reason.
Ganirelix should not be used in women who are already pregnant, and because of this the onset of pregnancy must be ruled out before it is administered. Women using ganirelix should not breast feed, as it is not known whether ganirelix is excreted in breast milk.
